Huge, bacteria-eating viruses could be a game-changer for antibiotics that currently struggle to fend off deadly infections.

Lung transplant recipients are highly susceptible to infection, the researchers noted, and P. aeruginosa is a leading cause ...

By combining MERFISH imaging with expansion microscopy, researchers have unlocked a new way to study bacteria at the ...

Integrating the nanoflowers into a wound dressing helps to fight harmful bacteria while keeping healthy human cells intact.

Strep throat, something we've all had at some point in our lives, is caused by the bacteria Streptococcus pyogenes. Infection ...

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...

In the face of rising concerns about antibiotic resistant infections, an international group of microbial experts have ...

The need for new fast classification methods has become increasingly important. When a patient arrives at a medical center ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

Discover the importance of antibiotics, bacterial cell walls, and resistance mechanisms in fighting bacterial infections effectively.